Dictyostelium discoideum: A Model System to Study LRRK2-Mediated Parkinson Disease

نویسندگان

  • Arjan Kortholt
  • Bernd Gilsbach
  • Peter J.M. van Haastert
چکیده

Parkinson disease (PD) is a neurodegenerative disease that affects more than 5 million people worldwide and one in hundred people over the age of 60. PD is both a chronic and degenerative disorder that is characterized by loss of dopaminergic neurons in the substantia nigra, associated with the formation of fibrillar aggregates composed of synuclein and other proteins (Lees et al., 2009). PD is clinically characterized by tremor, bradykinesia, rigidity and postural instability. Initially PD was considered to have no genetic cause, however many patients have one or more family member with the disease and genome-wide association studies identified a number of genetic factors segregating with PD (Satake et al., 2009; Simon-Sanchez et al., 2009). Therefore, it is now general believed that PD is caused by a combination of genetic and environmental factors. Recently, missense mutations in LRRK2 have been linked to autosomal-dominant, late-onset PD (Zimprich et al., 2004;Paisan-Ruiz et al., 2004). LRRK2 is a member of the novel Roco family of complex Ras-like GTPases that have an unique domain architecture (Fig. 1) (Bosgraaf and van Haastert, 2003). Roco proteins are characterized by the presence of a Ras-like Guanine nucleotide binding domain, called Roc (Ras of complex proteins), followed by a conserved stretch of 300-400 amino-acids with no significant homology to other described protein domains called the COR domain (C-terminal of Roc; Fig. 1). The Roc and COR domains always occurs as a pair, and so far no proteins have been identified containing either the Roc or COR domain alone, suggesting that these two domains function as one inseparable unit. Roco proteins were first identified in the social amoeba Dictyostelium discoideum and are found in prokaryotes, plants and metazoa, but not in Plasmodium and yeast (Bosgraaf et al., 2003). Besides a Roc and COR domain, all Roco proteins contain an N-terminal stretch of leucine-rich repeats (LRR), which are supposed to be involved in protein-protein interaction. A large group of Roco proteins, which is only present in Dictyostelium and metazoan, contains an additional C-terminal kinase domain of the MAPKKK subfamily of kinases. Next to this general domain composition, individual Roco proteins are found to be combined with a diversity of additional domains such as Guanine nucleotide exchange factor (GEF) and Regulator of G-protein Signalling (RGS) domains, implicating a link between traditional G-protein signalling pathways and Roco proteins (Bosgraaf et al., 2003). The identification of missense mutations in LRRK2 has redefined the role of genetic variation in PD susceptibility. LRRK2 mutations initiate a penetrant phenotype with

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations.

Mutations in human leucine-rich-repeat kinase 2 (LRRK2) have been found to be the most frequent cause of late-onset Parkinson disease. Here we show that Dictyostelium discoideum Roco4 is a suitable model to study the structural and biochemical characteristics of the LRRK2 kinase and can be used for optimization of current and identification of new LRRK2 inhibitors. We have solved the structure ...

متن کامل

Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation

Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain. Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD). Several of the pathogenic mutations in LRRK2 result in decreased GTPase act...

متن کامل

P 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease

Parkinson’s disease is the second most common age associated neuron degenerative disorder in developed societies. With the prevalence ranging from 41 per 100000 in the fourth decade of life to over 1900 per 100000 in people over 80 years of age.it characterized clinically by resting tremor, slowness of movement, rigidity and postural instability in the result of progressive loss of dopami...

متن کامل

The Roco protein family: a functional perspective.

In this review, we discuss the evolutionary, biochemical, and functional data available for members of the Roco protein family. They are characterized by having a conserved supradomain that contains a Ras-like GTPase domain, called Roc, and a characteristic COR (C-terminal of Roc) domain. A kinase domain and diverse regulatory and protein-protein interaction domains are also often found in Roco...

متن کامل

The Parkinson disease gene LRRK2: evolutionary and structural insights.

Mutations in the human leucine-rich repeat kinase 2 (LRRK2) gene are associated with both familial and sporadic Parkinson disease (PD). LRRK2 belongs to a gene family known as Roco. Roco genes encode for large proteins with several protein domains. Particularly, all Roco proteins have a characteristic GTPase domain, named Roc, plus a domain of unknown function called COR. In addition, LRRK2 and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012